Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Data from phase II studies of VAL-083 in glioblastoma

Dec. 7, 2020

New IDO-1 inhibitors synthesized at Hutchison MediPharma

Dec. 7, 2020

Jiangsu Hansoh Pharmaceutical, Shanghai Hansoh Biomedical patent RET inhibitors

Dec. 7, 2020

Ascentawits Pharmaceuticals discovers AKR1C3-activatable DNA alkylating drugs

Dec. 7, 2020

New MAPK 1 inhibitors identified at Medshine Discovery

Dec. 7, 2020

Phase III study of masitinib in first-line pancreatic cancer with pain shows survival increase

Dec. 4, 2020

Henan Zhiwei Biomedicine, Henan Normal University present new BTK inhibitors

Dec. 4, 2020

New EGFR inhibitors discovered at Zhejiang University

Dec. 4, 2020

Sirnaomics to start phase I trial of STP-705 in liver cancer

Dec. 4, 2020

Telix cleared to begin first-in-human study of TLX-592 for prostate cancer

Dec. 4, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...